CG&D
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cell Growth & Differentiation

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Turley, J. M.
Right arrow Articles by Birchenall-Roberts, M. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Turley, J. M.
Right arrow Articles by Birchenall-Roberts, M. C.

Cell Growth & Differentiation, Vol 7, Issue 11 1535-1544, Copyright © 1996 by American Association of Cancer Research


ARTICLES

Transforming growth factor beta 1 functions in monocytic differentiation of hematopoietic cells through autocrine and paracrine mechanisms

JM Turley, LA Falk, FW Ruscetti, JJ Kasper, T Francomano, T Fu, OS Bang and MC Birchenall-Roberts
Laboratory of Leukocyte Biology, National Cancer Institute, Frederick, Maryland 21702, USA.

This study examined the role of transforming growth factor beta 1 (TGF-beta 1) in monocytic differentiation of hematopoietic cells. TGF-beta 1 and retinoic acid (RA) inhibited HL-60 cell growth in a dose-dependent fashion. Treatment of HL-60 cells with a combination of TGF-beta 1 and a 50% optimal dose of RA (RA + TGF-beta 1) resulted in increased growth suppression compared to the individual treatments. Morphological studies revealed that TGF-beta 1 induced promonocytic differentiation (68%), RA induced granulocytic differentiation (98%), and RA + TGF-beta 1 induced monocytic (54%) and granulocytic (46%) differentiation of HL-60 cells. Induction of the monocyte-specific marker, nonspecific esterase, was markedly increased by TGF-beta 1 and RA + TGF-beta 1 treatment but not by RA treatment. Both TGF-beta 1 treatment and RA treatment increased TGF-beta ligand and TGF-beta receptor protein and mRNA levels. To determine whether RA mediated HL-60 cell growth inhibition and differentiation through the autocrine expression of TGF-beta 1, experiments using TGF-beta 1 antisense oligonucleotides or TGF-beta 1-neutralizing antibodies were conducted. TGF-beta 1 antisense oligonucleotides and neutralizing antibodies partially blocked RA-induced inhibition of proliferation, and TGF-beta 1 antisense oligonucleotides reversed RA-induced granulocytic maturation, demonstrating that RA signals autocrine expression of TGF-beta 1 and TGF-beta receptors. The effect of TGF-beta 1 on normal hematopoiesis was also studied using primary human fetal liver cells. TGF-beta 1 alone and in the presence of interleukin 3 promoted macrophage differentiation of primitive fetal liver cells. Cell surface expression of the monocyte/macrophage-specific marker c-fms was increased 3.1-fold following TGF-beta 1 treatment. In addition, TGF-beta 1-treated cells displayed a 51% increase in phagocytosis as compared to interleukin 3-treated control cells. These studies define a role for TGF-beta 1 in the autocrine and paracrine regulation of monocyte/macrophage differentiation.


This article has been cited by other articles:


Home page
J. Immunol.Home page
T. Wu, C. Sun, Z. Chen, Y. Zhen, J. Peng, Z. Qi, X. Yang, and Y. Zhao
Smad3-Deficient CD11b+Gr1+ Myeloid-Derived Suppressor Cells Prevent Allograft Rejection via the Nitric Oxide Pathway
J. Immunol., November 15, 2012; 189(10): 4989 - 5000.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
E. A. Ansa-Addo, S. Lange, D. Stratton, S. Antwi-Baffour, I. Cestari, M. I. Ramirez, M. V. McCrossan, and J. M. Inal
Human Plasma Membrane-Derived Vesicles Halt Proliferation and Induce Differentiation of THP-1 Acute Monocytic Leukemia Cells
J. Immunol., November 1, 2010; 185(9): 5236 - 5246.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
Z. Cao, K. C. Flanders, D. Bertolette, L. A. Lyakh, J. U. Wurthner, W. T. Parks, J. J. Letterio, F. W. Ruscetti, and A. B. Roberts
Levels of phospho-Smad2/3 are sensors of the interplay between effects of TGF-beta and retinoic acid on monocytic and granulocytic differentiation of HL-60 cells
Blood, January 15, 2003; 101(2): 498 - 507.
[Abstract] [Full Text] [PDF]


Home page
Ann Clin Lab SciHome page
R. E. Brown and N. R. Kamal
The Reed-Sternberg Cell: Molecular Characterization by Proteomic Analysis with Therapeutic Implications
Ann. Clin. Lab. Sci., October 1, 2002; 32(4): 339 - 351.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
N. O. Fortunel, A. Hatzfeld, and J. A. Hatzfeld
Transforming growth factor-beta : pleiotropic role in the regulation of hematopoiesis
Blood, September 15, 2000; 96(6): 2022 - 2036.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Sci.Home page
P. Batard, M. N. Monier, N. Fortunel, K. Ducos, P. Sansilvestri-Morel, T. Phan, A. Hatzfeld, and J. A. Hatzfeld
TGF-(beta)1 maintains hematopoietic immaturity by a reversible negative control of cell cycle and induces CD34 antigen up-modulation
J. Cell Sci., February 1, 2000; 113(3): 383 - 390.
[Abstract] [PDF]


Home page
BloodHome page
L. E. Purton, I. D. Bernstein, and S. J. Collins
All-Trans Retinoic Acid Delays the Differentiation of Primitive Hematopoietic Precursors (lin-c-kit+Sca-1+) While Enhancing the Terminal Maturation of Committed Granulocyte/Monocyte Progenitors
Blood, July 15, 1999; 94(2): 483 - 495.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Sci.Home page
S. J. Kim, O. S. Bang, Y. S. Lee, and S. S. Kang
Production of inducible nitric oxide is required for monocytic differentiation of U937 cells induced by vitamin E-succinate
J. Cell Sci., February 1, 1998; 111(4): 435 - 441.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cell Growth & Differentiation
Copyright © 1996 by the American Association of Cancer Research.